The healthcare giant is dealing with the fast-approaching patent cliff for its most important product, cancer medicine ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs ...

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways ...

Argus has a "buy" rating and $185 price target for JNJ stock, which closed at $146.64 on Jan. 23. AbbVie is a global pharmaceutical company. Its key drugs include Humira for treating rheumatoid ...

While most analysts do not wish to hazard a guess if the worst is over for the markets, the current fall, they suggest, ...

Brokerages Motilal Oswal and Jefferies have maintained positive outlooks for ICICI Bank, Torrent Pharmaceuticals, and Godrej ...

If you're too busy to keep monitoring your stock portfolio every other day ... Beyond that, the pharmaceutical company has a robust pipeline. Its weight loss candidates, including retatrutide ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a decline, ending the day at $439.62 which represents a decrease of $-0.11 or -0.03% from the prior close of $439.73. The stock opened at $438.73 and ...

Citi analyst increased the price target for Torrent Pharma (TRP:IN) to INR4,000, up from INR3,940, while reiterating a Buy ...

We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...

Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...